Phase
Condition
Pain
Acute Pain
Treatment
Suzetrigine
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
Body mass index (BMI) of greater than or equal to (≥)18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m^2)
Participants scheduled to undergo an aesthetic or reconstructive surgical procedurethat would typically be treated with opioid therapy for at least 72 hourspostoperatively
Exclusion
Key Exclusion Criteria:
• Participated in a previous study with SUZ or received Journavx
Other protocol defined Inclusion/Exclusion criteria may apply.
Study Design
Connect with a study center
Atlanta Center for Medical Research
Atlanta, Georgia 30331
United StatesSite Not Available
Atlanta Center for Medical Research
Atlanta 4180439, Georgia 4197000 30331
United StatesSite Not Available
Beth Israel Deaconess Medical Center - Surgery
Boston 4930956, Massachusetts 6254926 02215
United StatesSite Not Available
HD Research LLC | First Surgical Hospital
Bellaire, Texas 77401
United StatesSite Not Available
Memorial Hermann Village
Houston, Texas 77043
United StatesSite Not Available
HD Research LLC | First Surgical Hospital
Bellaire 4673353, Texas 4736286 77401
United StatesSite Not Available
Memorial Hermann Village
Houston 4699066, Texas 4736286 77043
United StatesSite Not Available
JBR Clinical Research
Salt Lake City, Utah 84107
United StatesSite Not Available
JBR Clinical Research
Salt Lake City 5780993, Utah 5549030 84107
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.